Clinical Trial Update: Effect of IVIG on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer Disease [Phase 2]

View source ↗

Summary

Phase 2 trial investigating intravenous immunoglobulin (IVIG) for cerebral and retinal amyloid in mild cognitive impairment due to Alzheimer disease has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Sutter Health | Conditions: Mild Cognitive Impairment | Phase 2 | Status: COMPLETED | Results posted: 2019-04-16